Company news
Illumina, Inc. news in 2021
Illumina, Inc.'s news releases, calls and decks from 2021, newest first.
Illumina Supports Norway's Pioneering Precision Medicine Study
December 8, 2021
Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in China
November 16, 2021
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
November 15, 2021
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021
November 3, 2021
Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative
November 2, 2021
Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill Newborns with Suspected Genetic Disease
October 26, 2021
Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021
October 19, 2021
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL
October 13, 2021
Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
October 12, 2021
Illumina Expands Presence in Latin America
September 29, 2021
Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants
September 26, 2021
Illumina Ventures Closes $325 Million Fund
September 19, 2021
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
September 14, 2021
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
September 8, 2021
Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
September 6, 2021
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
August 17, 2021
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021
August 4, 2021
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
August 3, 2021
Illumina to Webcast Upcoming Investor Conference
July 27, 2021
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
July 21, 2021
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
July 12, 2021
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
May 31, 2021
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
May 30, 2021
Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
May 16, 2021
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
April 28, 2021
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
April 27, 2021
Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
April 26, 2021
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
April 21, 2021
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
April 19, 2021
Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
April 4, 2021
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
March 29, 2021
Illumina Announces Board Changes
March 17, 2021
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
March 10, 2021
Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
March 4, 2021
Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases
February 18, 2021
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2020
February 10, 2021
Illumina to Webcast Upcoming Investor Conference Presentations
February 9, 2021
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
February 7, 2021
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
February 3, 2021
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
January 30, 2021
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
January 24, 2021
Illumina Wins Patent Infringement Suit against BGI in the UK
January 19, 2021
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling
January 10, 2021
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure
January 4, 2021
Calls in 2021
Decks in 2021
- J.P. Morgan 39th Annual Healthcare Conference (January 2021)
Conference · 29 slides · Jan 11, 2021